Life Sciences Tools and Services
Company Overview of Retina Implant AG
Retina Implant AG researches, develops, and produces medical products for visually handicapped and blind patients. It primarily focuses on the development of subretinal implants. The company was founded in 2003 and is based in Reutlingen, Germany.
Founded in 2003
Key Executives for Retina Implant AG
Chief Executive Officer, President and Director
Compensation as of Fiscal Year 2014.
Retina Implant AG Key Developments
Retina Implant AG Announces Multicenter Clinical Trial Results at Spain's Ophthalmology Congress
Mar 10 14
Retina Implant AG announced that Angelika Braun, clinical engineer at Retina Implant AG, presented results from the Company's multicenter clinical trial for the first time in Spain at the XVII Congreso de Sociedad Espanola de Retina y Vitreo (SERV) 2014. SERV 2014 took place 7-8 March at the Palacio de Exposiciones y Congresos de Sevilla in Sevilla, Spain. As part of the trial, study participants were implanted with Retina Implant's Alpha IMS device, a small, wireless microchip that is implanted below the retina, specifically in the macular region. The microchip mimics the function of the photoreceptors within the eye and has shown to restore partial vision to those blinded for years, allowing them to perceive light, detect motion, read letters and perform daily tasks with improved acuity and mobility in everyday life. Braun's presentation, 'Ver con un implante electronico subretinal en la vida diaria', featured results from a subset of nine patients in the trial. Functional vision was restored in the majority of these patients, enabling improved function in everyday life. Examples include the ability to recognize faces, distinguish objects such as telephones and read signs on doors.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries